IntroductionPeople often think they know what causes chronic depression. Surveys indicate that more than 80% of the public blames a “chemical imbalance” in the...
Camardo to lead Company’s transition to a commercial-stage company CLEVELAND–(BUSINESS WIRE)–$ATHX #Athersys–Athersys, Inc. (Nasdaq: ATHX), an international, late-stage, regenerative medicine company, announced today the appointment of Daniel A. Camardo as the Company’s Chief Executive Officer, effective February 14, 2022. Mr. Camardo is a senior pharmaceutical and biotech executive with more than 25 years of commercial […]
The causes of aging are extremely complex and unclear. But with longevity clinical trials increasing, more answers—and questions—are emerging than ever before.
With the...